Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
64.72B
Market cap64.72B
Price-Earnings ratio
18.09
Price-Earnings ratio18.09
Dividend yield
Dividend yield
Average volume
24.12M
Average volume24.12M
High today
High today
Low today
Low today
Open price
$45.05
Open price$45.05
Volume
7.03K
Volume7.03K
52 Week high
$105.65
52 Week high$105.65
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $44.47, with a market capitalization of 64.72B. The stock trades at a price-to-earnings (P/E) ratio of 18.09.

On 2026-09-24, Boston Scientific(BSX) stock opened at $45.05, reached a high of —, and a low of —.

The Boston Scientific(BSX)'s current trading volume is 7.03K, compared to an average daily volume of 24.12M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

BSX News

TipRanks 53m
Boston Scientific price target lowered to $48 from $50 at Wells Fargo

Wells Fargo lowered the firm’s price target on Boston Scientific (BSX) to $48 from $50 and keeps an Equal Weight rating on the shares. The firm is lowering its...

Simply Wall St 9h
Boston Scientific Could Be 27% Undervalued Following Earnings Growth Focus - simplywall.st

...

Boston Scientific Could Be 27% Undervalued Following Earnings Growth Focus - simplywall.st
TipRanks 1d
Boston Scientific Announces Retirement of MedSurg, Asia Pacific Chief

Boston Scientific ( (BSX) ) has shared an announcement. Boston Scientific said that on September 21, 2026, Arthur C. Butcher informed the company he will retir...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More BSX News

Simply Wall St 2d
Is Software Recall Risk Altering The Investment Case For Boston Scientific Stock?

Boston Scientific issued voluntary Class II recalls for its LUX-Dx Insertable Cardiac Monitor server software worldwide after FDA enforcement reports highlighte...

Is Software Recall Risk Altering The Investment Case For Boston Scientific Stock?
TipRanks 3d
Option traders moderately bearish in Boston Scientific with shares down 0.38%

Option traders moderately bearish in Boston Scientific (BSX), with shares down 16c near $43.17. Options volume relatively light with 11k contracts traded and ca...

Nasdaq 3d
New Strong Sell Stocks for September 21st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: AGCO Corporation AGCO is an agricultural equipment manufacturing company. The Zacks...

New Strong Sell Stocks for September 21st
Simply Wall St 5d
Boston Scientific Stock Could Be A Bargain On Strong Cash Flow Views

has seen a sharp reset in its share price over the past year, which puts a fresh spotlight on whether today's valuation is still supported by the cash the busin...

Boston Scientific Stock Could Be A Bargain On Strong Cash Flow Views
TipRanks 5d
Trip.com, Boston Scientific, Lyft, WES, Magna Trending With Analysts

Analysts are intrested in these 5 stocks: ( (TCOM) ), ( (BSX) ), ( (LYFT) ), ( (WES) ) and ( (MGA) ). Here is a breakdown of their recent ratings and the ration...

TipRanks 6d
Boston Scientific Advances Eso-SPONGE Trial, Targeting GI Leak Treatment and New Growth

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific Corp. is launching a new multicenter trial called “A Prospective...

TipRanks 6d
Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, with a price target of $56.00. Josh Jennings has given his Buy rating due to a c...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.